-

Trinity Life Sciences Launches Healthcheck Suite

Healthcheck Assessments Provide Expert Evaluation and Advisory Services for
Life Sciences Companies Ready to Evolve AIML, Omnichannel and Data Management Capabilities

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the creation of the Trinity Healthcheck suite to identify areas of opportunity and provide comprehensive, actionable recommendations for enhancing overall readiness and performance. The assessments objectively evaluate the current state of a life sciences company’s operations, including strategy, processes, technology and talent. The suite includes three types of assessments with the following areas of focus and recommendation:

Artificial Intelligence & Machine Learning (AIML) Readiness Healthcheck

- Untapped business applications, machine learning (ML) operations and ecosystem, organizational structure, model performance and optimization

Omnichannel Activation Healthcheck

- Omnichannel and performance data, planning, execution and measurement, organizational structure and change management to help drive adoption

Data Quality and Management Healthcheck

- Data strategy and acquisition, operations, analytics enablement, privacy and security, master data management and governance

Trinity’s experts evaluate life sciences companies’ current state using a combination of qualitative and quantitative methods, including stakeholder interviews, brainstorming workshops, process mapping and data/model analysis. Recommendations, based on best practices and industry benchmarks from TGaS Advisors, a division of Trinity Life Sciences, are customized to align to the organization’s short- and long-term strategic goals and vision.

“Life sciences companies are eager to leverage new technology and sophisticated analytical methods to guide decision-making. But they often run into challenges such as implementing change management or handling growing volumes of data. An expert evaluation of a company's current state in comparison to the industry—with guidance on next steps—is often welcome," explained Neal Dunn, Senior Partner and Head of Analytics at Trinity Life Sciences. "We created Trinity Healthchecks to provide customized roadmaps detailing where and how companies can quickly make progress in areas there is great opportunity."

Life sciences executives can book a Trinity Healthcheck here.

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With over 25 years of experience, Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

Media:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Versions

Contacts

Media:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Social Media Profiles
More News From Trinity Life Sciences

Trinity Appoints Scott Evangelista as CEO to Lead Next Chapter

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced Scott Evangelista has been appointed Chief Executive Officer, succeeding Leslie Orne who is stepping down after three years as CEO and over 24 years with the company. Ms. Orne will transition to the role of Senior Advisor and serve as a member of Trinity’s Board of Directors. Over her distinguished tenure, Ms. Orne helped guide Trinity’s evo...

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization, today announced the release of its 5th Annual TGaS Digital Marketing Competency Report, a three-part series benchmarking the digital marketing presence of more than 150 biopharma brands. The 2025 edition reveals a significant leap forward in the industry’s digital sophistication, with a 19% increase in Proficient brands and a surge of innovation in patient engagement strategies. The report ranks each b...

Trinity Expands Global Footprint with Acquisition of EVERSANA’s APACME Advisory Services

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization solutions and recognized for being a strategic, tech-enabled commercialization company that empowers pharma, biotech, and medtech organizations to advance medical innovations, announced today the acquisition of EVERSANA’s advisory services operation in Asia-Pacific and the Middle East (APACME). The strategic acquisition will transition EVERSANA’s advisory services operation in APACME to Trinity, further...
Back to Newsroom